The Immunotoxin market accounted for USD 168.5 Million in 2024 and is expected to reach USD 388.9 Million by 2035, growing at a CAGR of around 7.9% between 2025 and 2035. The immunotoxin market includes firms that research, develop, and sell immunotoxins, which are bioactive molecules made up of a toxin and an antibody, or a combination of the two.
Npr Building Concepts
Dewabos138
Kenai Escorts
White Grady
Shah Watson
Patriots Rv Services
Hunt Isaksen
Bong88
Hjort Huber
Suveni Rov